Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01875796 · ClinicalTrials.gov registry record · Phase 1
Integrated CBT for Cannabis Dependence With Co-occurring Anxiety Disorders
A Phase 1 study of Anxiety Disorders and Cannabis Use Disorder, sponsored by Louisiana State University and A&M College.
- Completed
- Registry status
- Phase 1
- Development phase
- 68
- Enrollment target
- 1
- Study location
NCT01875796: Completed Phase 1 study of Anxiety Disorders and Cannabis Use Disorder, sponsored by Louisiana State University and A&M College.
NCT01875796 is a Phase 1 study of Anxiety Disorders and Cannabis Use Disorder that has completed, run by Louisiana State University and A&M College. The registered enrollment target is 68 participants, below the 1,139-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01875796, a Phase 1 study of Anxiety Disorders and Cannabis Use Disorder, has completed, sponsored by Louisiana State University and A&M College.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 68 participants
- Enrollment target
- 1
- Study location
Study Summary
This project tests the feasibility and utility of a novel, integrated approach to treatment of patients with cannabis use disorder (CUD) and anxiety disorders.
Conditions Studied
Interventions
- BEHAVIORAL Cognitive-Behavioral Therapy
- BEHAVIORAL Motivation Enhancement Therapy
- BEHAVIORAL Integrated Cannabis and Anxiety Reduction Treatment
- BEHAVIORAL False Safety Behavior Elimination Therapy
Study Locations (1)
Louisiana
- Louisiana State University Anxiety & Addictive Behaviors Clinic - Baton Rouge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2013-06 |
| Phase | Phase 1 |
What the finished NCT01875796 record still lists
NCT01875796 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 68 participants, a relatively small participant target, below the 1,139-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (94% lower).
The record links to 4 conditions, with Anxiety Disorders appearing as the primary indexed condition, and to 4 interventions - of which Cognitive-Behavioral Therapy is the first listed.
NCT01875796 reports a single indexed study location in Louisiana.
Frequently Asked Questions
What is clinical trial NCT01875796 about?
NCT01875796 is a clinical study titled "Integrated CBT for Cannabis Dependence With Co-occurring Anxiety Disorders". This project tests the feasibility and utility of a novel, integrated approach to treatment of patients with cannabis use disorder (CUD) and anxiety disorders.
What is the current status of trial NCT01875796?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 68 participants. The study started on 2013-06.
What conditions does trial NCT01875796 study?
This clinical trial studies the following conditions: Anxiety Disorders, Cannabis Use Disorder, Cannabis Dependence, Cannabis Abuse.
What interventions are being tested in trial NCT01875796?
The interventions under investigation include: Cognitive-Behavioral Therapy (BEHAVIORAL), Motivation Enhancement Therapy (BEHAVIORAL), Integrated Cannabis and Anxiety Reduction Treatment (BEHAVIORAL), False Safety Behavior Elimination Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT01875796?
This trial is sponsored by Louisiana State University and A&M College, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01875796 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01875796's enrollment target sits among peer trials
68 60th of 84 higher than 25 of 84 other Anxiety Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anxiety Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Antiglucocorticoid Therapy for Cognitive Impairment in Late-life Anxiety Disorders
COMPLETED · Phase 1
-
Mindfulness-based Stress Reduction and Cognitive Function in Stress and Aging
COMPLETED · Phase 1
-
Treatment for Specific Phobias in Children
COMPLETED · Phase 1
-
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
RECRUITING · NA
-
CRISOL Mente: A Multilevel Community Intervention to Reduce Mental Health Disparities Among Latinos
RECRUITING · NA
-
Trial With the Treatment of Sertraline in Youth With Generalized, Separation and/or Social Anxiety Disorders.
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia